Intermediate Size Expanded Access Protocol for the Treatment of Post-COVID-19 Syndrome

A Study Evaluating ABI-H0731 as Adjunctive Therapy in Participants With Chronic Hepatitis B Infection

NCT03576066 ·Status: COMPLETED ·Phase: PHASE2

A Phase II Study of Hepalatide in Subjects With Chronic Hepatitis B

NCT04426968 ·Status: COMPLETED ·Phase: PHASE2

An Exploratory Clinical Study Evaluating EPI-003 Injection for the Treatment of Chronic Hepatitis B

NCT06745973 ·Status: NOT_YET_RECRUITING ·Phase: EARLY_PHASE1

A Study of JNJ-73763989, JNJ-56136379, Nucleos(t)Ide Analogs, and Pegylated Interferon Alpha-2a in Virologically Suppressed Participants With Chronic Hepatitis B Virus Infection

NCT04667104 ·Status: COMPLETED ·Phase: PHASE2

Study of EPI-003 in Select Nucleos(t)Ide Analogue-Treated, Chronic Hepatitis B Patients

NCT06661148 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

A Trial To Evaluate The Efficacy And Safety Of Multiple Combination Therapies In Participants With Chronic Hepatitis B

NCT04225715 ·Status: COMPLETED ·Phase: PHASE2

An Efficacy and Safety Study of a Combination of JNJ-73763989, Nucleos(t)Ide Analogs (NA), and a Programmed Cell Death Protein Receptor-1 (PD-1) Inhibitor in Chronic Hepatitis B Participants

NCT05275023 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of Therapeutic Hepatitis B Adenovirus Injection (T101) Combined With Nucleoside (Acid) Analogues in Chronic Hepatitis B Patients

NCT04189276 ·Status: UNKNOWN ·Phase: PHASE2

Using Entecavir to Reduce Hepatitis in Highly Viremic HBV Patients During Anti-tuberculous Treatment

NCT01724723 ·Status: UNKNOWN ·Phase: PHASE4

Safety, Tolerability, and Pharmacokinetics of AB-836 in Healthy Subjects and Subjects With Chronic HBV Infection

NCT04775797 ·Status: TERMINATED ·Phase: PHASE1

Tolerability, Immunogenicity and Efficacy of HB-110 Administered by Electroporation in Chronic Hepatitis B Patients

NCT01641536 ·Status: COMPLETED ·Phase: PHASE1

Plasma Purification and Chronic Hepatitis B

NCT04518553 ·Status: UNKNOWN ·Phase: NA

Clinical Trials of the Hepatitis B Sandwich Combination Therapy for Treating Patients Infected With Hepatitis B Virus

NCT07088133 ·Status: NOT_YET_RECRUITING ·Phase: NA

Clinical Efficacy of Pegylated Interferon Alpha-2b Combined With Nucleos(t)Ide Analogues in the Treatment of Chronic Hepatitis B Patients

NCT07071636 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

A Study in Healthy Volunteers and Patients With Chronic Hepatitis B

NCT02908191 ·Status: COMPLETED ·Phase: PHASE1

Treatment of Patients With Chronic Hepatitis B With Hepatitis B Immunoglobulins

NCT05345990 ·Status: TERMINATED ·Phase: PHASE2

Phase 1 Study of HT-102 Administered Subcustaneously in Healthy Participants and Patients with Chronic Hepatitis B for Safety, Tolerability, Pharmacokinetics (PK), and Antiviral Activity (only in Participants with Chronic HBV Infection)

NCT06744686 ·Status: COMPLETED ·Phase: PHASE1

Phase 1 Study to Evaluate Safety and Antiviral Activity of PBGENE-HBV in Adult Patients With Chronic Hepatitis B

NCT06680232 ·Status: RECRUITING ·Phase: PHASE1

Phase I Study of INO-1800 With or Without INO-9112 + EP in Chronic Hepatitis B Subjects

NCT02431312 ·Status: COMPLETED ·Phase: PHASE1

Prophylactic Entecavir for HBV Reactivation in Past HBV Infected Patients With Hematopoietic Stem Cell Transplantation

NCT04942886 ·Status: ENROLLING_BY_INVITATION ·Phase: NA

HBV Reactivation in Anti CD20 Treatment

NCT05768061 ·Status: UNKNOWN

Safety, Tolerability, Pharmacokinetics(PK), Pharmacodynamics(PD) and Food Effect of HRS9950 in Healthy and CHB Subjects

NCT04464733 ·Status: COMPLETED ·Phase: PHASE1

Entecavir for Patients With Decompensated Hepatitis B Virus (HBV)-Related Cirrhosis

NCT00663182 ·Status: UNKNOWN ·Phase: PHASE4

Vaccinal Effect of HBsAg Monoclonal Ab VIR-3434 in Chronic Hepatitis B Infection [VISION]

NCT06216470 ·Status: RECRUITING ·Phase: PHASE2

A Study to Evaluate the Efficacy and Safety of HR19042 Capsules in the Treatment of Autoimmune Hepatitis.

NCT05476900 ·Status: COMPLETED ·Phase: PHASE2